TMSB10 and tuberculosis: The TB/FLU-05E vaccine, developed by the Smorodintsev Institute of Influenza in Russia, is designed to express MTB antigens TB10.4 and HspX, combined with the attenuated influenza strain A/PR8/NS124-TB10.4-2A-HspX [35].